Seattle Genetics Inc (SGEN) Posts Mixed Q2 Results
Tweet
Share
E-mailGet Alerts SGEN Hot Sheet
Price: $228.74 --0%
Financial Fact:
Net income (loss): -31.75M
Today's EPS Names:
VAXX, NMRD, EGRX, More
Financial Fact:
Net income (loss): -31.75M
Today's EPS Names:
VAXX, NMRD, EGRX, More
Join SI Premium – FREE
Seattle Genetics Inc (NASDAQ: SGEN) reported Q2 EPS of ($0.45), $0.06 worse than the analyst estimate of ($0.39). Revenue for the quarter came in at $13.1 million versus the consensus estimate of $10.97 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Forum Markets, Incorporated (FRMM) Tops Q2 EPS by 29c ; Offers Guidance
- Lucid Diagnostics Inc. (LUCD) Reports In-Line Q2 EPS
- NextPlat Corp (NXPL) Reports Q2 Loss of $0.05
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
